543346 Stock Overview
Aashka Hospitals Limited provides healthcare services in Gujarat, India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Aashka Hospitals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹80.10 |
52 Week High | ₹89.65 |
52 Week Low | ₹43.16 |
Beta | 0.59 |
1 Month Change | 5.39% |
3 Month Change | 7.62% |
1 Year Change | 55.14% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -30.38% |
Recent News & Updates
Recent updates
Shareholder Returns
543346 | IN Healthcare | IN Market | |
---|---|---|---|
7D | 0.9% | -3.7% | -1.6% |
1Y | 55.1% | 62.3% | 45.0% |
Return vs Industry: 543346 underperformed the Indian Healthcare industry which returned 62.3% over the past year.
Return vs Market: 543346 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
543346 volatility | |
---|---|
543346 Average Weekly Movement | 6.8% |
Healthcare Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543346 has not had significant price volatility in the past 3 months.
Volatility Over Time: 543346's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 238 | Bipin Shah | www.aashkahospitals.in |
Aashka Hospitals Limited provides healthcare services in Gujarat, India. The company provides anaesthesiology, cardiology, dermatology, nephrology, neurology, neurosurgery, obstetrics and gynecology, ophthalmology, pediatrics, and radiology services. It also provides orthopedics; dentistry; surgery; ENT; and critical care medicine and emergency services.
Aashka Hospitals Limited Fundamentals Summary
543346 fundamental statistics | |
---|---|
Market cap | ₹1.90b |
Earnings (TTM) | -₹16.72m |
Revenue (TTM) | ₹182.11m |
10.3x
P/S Ratio-112.0x
P/E RatioIs 543346 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
543346 income statement (TTM) | |
---|---|
Revenue | ₹182.11m |
Cost of Revenue | ₹35.17m |
Gross Profit | ₹146.94m |
Other Expenses | ₹163.66m |
Earnings | -₹16.72m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.72 |
Gross Margin | 80.69% |
Net Profit Margin | -9.18% |
Debt/Equity Ratio | 26.5% |
How did 543346 perform over the long term?
See historical performance and comparison